Janssen Presents Longer-Term Talquetamab Follow-Up Data
Additional long-term data from the TRiMM-2 study in patients receiving talquetamab and DARZALEX® (daratumumab) subcutaneous (SC) formulation combination...
Stay updated with breaking news from Programmed Cell Death. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Additional long-term data from the TRiMM-2 study in patients receiving talquetamab and DARZALEX® (daratumumab) subcutaneous (SC) formulation combination...
A ground-breaking study by Loughborough University and the University of Oxford has led to the development of a small molecule probe that could deepen our understanding of a crucial cellular messenger and lead to the development of new therapeutic drugs.
Using artificial intelligence, researchers from integrated biosciences have identified three senolytics with superior efficacy and drug-like properties relative to other compounds.
Despite the promise of new medications that promote cancer cell death in people with acute myeloid leukemia, leukemic cells often adopt features that let them evade the drugs' effects within a year.
Nature-based methodology created by BlueGreen Water Technologies facilitates the issuance of carbon credits from harmful algal bloom remediation